HR 4993 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Joe Fiandra Access to Home Infusion Act of 2025
To amend title XVIII of the Social Security Act to provide coverage of external infusion pumps and non-self-administrable home infusion drugs under the Medicare program.
Summary
The bill amends Medicare to cover external infusion pumps and certain non-self-administrable home infusion drugs starting one year after enactment, even if they do not meet standard "appropriate for use in the home" requirements for durable medical equipment. Medicare coverage is available when the drug's FDA-approved prescribing information requires administration by or under supervision of a healthcare professional, a qualified home infusion therapy supplier administers or supervises the administration in the patient's home, and the drug is prescribed to be infused at least 12 times per year by intravenous or subcutaneous methods or at rates requiring an external pump. The bill also requires the Secretary of Health and Human Services to notify Medicare patients about the cost-sharing differences between home infusion therapy and other care settings for infusion drugs.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
6 cosponsors
Money behind the sponsor
Top reported contributors to Brian K. Fitzpatrick’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Brian K. Fitzpatrick → · Outside spending →
Actions (4)
- Dec 10, 2025 Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0. · house
- Dec 10, 2025 Committee Consideration and Mark-up Session Held · house
- Aug 19, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · house
- Aug 19, 2025 Introduced in House
More bills on these subjects (8)
Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
August 19, 2025
Mr. Fitzpatrick (for himself, Mr. Dunn of Florida, and Mr. Soto) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
A BILL
To amend title XVIII of the Social Security Act to provide coverage of external infusion pumps and non-self-administrable home infusion drugs under the Medicare program.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Joe Fiandra Access to Home Infusion Act of 2025”.
SEC. 2. MEDICARE COVERAGE OF EXTERNAL INFUSION PUMPS AND NON-SELF- ADMINISTRABLE HOME INFUSION DRUGS.
(a) In General.—Section 1861(n) of the Social Security Act (42 U.S.C. 1395x(n)) is amended by adding at the end the following new sentence: “Beginning with the first calendar quarter beginning on or after the date that is 1 year after the date of the enactment of this sentence, an external infusion pump and associated home infusion drug (as defined in subsection (iii)(3)(C)) or other associated supplies that do not meet the appropriate for use in the home requirement applied to the definition of durable medical equipment under section 414.202 of title 42, Code of Federal Regulations (or any successor to such regulation) shall be treated as meeting such requirement if each of the following criteria is satisfied:
“(1) The prescribing information approved by the Food and Drug Administration for the home infusion drug associated with the pump instructs that the drug should be administered by or under the supervision of a health care professional.
“(2) A qualified home infusion therapy supplier (as defined in subsection (iii)(3)(D)) administers or supervises the administration of the drug or biological in a safe and effective manner in the patient’s home (as defined in subsection (iii)(3)(B)).
“(3) The prescribing information described in paragraph
(1) instructs that the drug should be infused at least 12 times per year—
“(A) intravenously or subcutaneously; or
“(B) at infusion rates that the Secretary determines would require the use of an external infusion pump.”.
(b) Cost Sharing Notification.—The Secretary of Health and Human Services shall ensure that patients are notified of the cost sharing for electing home infusion therapy compared to other applicable settings of care for the furnishing of infusion drugs under the Medicare program. <all>
Comments